Antiviral Activities of Eucalyptus Essential Oils: Their Effectiveness as Therapeutic Targets against Human Viruses

被引:48
作者
Mieres-Castro, Daniel [1 ,2 ]
Ahmar, Sunny [1 ]
Shabbir, Rubab [3 ]
Mora-Poblete, Freddy [2 ]
机构
[1] Natl Fund Sci & Technol Dev, Av Agua 3895, Talca 3460000, Chile
[2] Univ Talca, Inst Biol Sci, 1 Poniente 1141, Talca 3465548, Chile
[3] Univ Agr Faisalabad, Seed Sci & Technol, Faisalabad 38040, Pakistan
关键词
Eucalyptus essential oil; 1; 8-cineole; antiviral therapy; herpes simplex virus; SARS-CoV-2; HERPES-SIMPLEX-VIRUS; TEA TREE; CHEMICAL-COMPOSITION; INFLUENZA-VIRUS; DOUBLE-BLIND; CINEOLE; TYPE-1;
D O I
10.3390/ph14121210
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Given the limited therapeutic management of infectious diseases caused by viruses, such as influenza and SARS-CoV-2, the medicinal use of essential oils obtained from Eucalyptus trees has emerged as an antiviral alternative, either as a complement to the treatment of symptoms caused by infection or to exert effects on possible pharmacological targets of viruses. This review gathers and discusses the main findings on the emerging role and effectiveness of Eucalyptus essential oil as an antiviral agent. Studies have shown that Eucalyptus essential oil and its major monoterpenes have enormous potential for preventing and treating infectious diseases caused by viruses. The main molecular mechanisms involved in the antiviral activity are direct inactivation, that is, by the direct binding of monoterpenes with free viruses, particularly with viral proteins involved in the entry and penetration of the host cell, thus avoiding viral infection. Furthermore, this review addresses the coadministration of essential oil and available vaccines to increase protection against different viruses, in addition to the use of essential oil as a complementary treatment of symptoms caused by viruses, where Eucalyptus essential oil exerts anti-inflammatory, mucolytic, and spasmolytic effects in the attenuation of inflammatory responses caused by viruses, in particular respiratory diseases.
引用
收藏
页数:18
相关论文
共 69 条
[1]  
Abbass HS, 2020, Universal Journal of Pharmaceutical Research, V5, P61, DOI [DOI 10.22270/UJPR.V5I4.440, 10.22270/ujpr.v5i4.440]
[2]   Repellent and Larvicidal Activity of the Essential Oil From Eucalyptus nitens Against Aedes aegypti and Aedes albopictus (Diptera: Culicidae) [J].
Alvarez Costa, Agustin ;
Naspi, Cecilia V. ;
Lucia, Alejandro ;
Masuh, Hector M. .
JOURNAL OF MEDICAL ENTOMOLOGY, 2017, 54 (03) :670-676
[3]   COVID-19 and therapy with essential oils having antiviral, anti-inflammatory, and immunomodulatory properties [J].
Asif, Muhammad ;
Saleem, Mohammad ;
Saadullah, Malik ;
Yaseen, Hafiza Sidra ;
Al Zarzour, Raghdaa .
INFLAMMOPHARMACOLOGY, 2020, 28 (05) :1153-1161
[4]   Comparative Study on the Antiviral Activity of Selected Monoterpenes Derived from Essential Oils [J].
Astani, Akram ;
Reichling, Juergen ;
Schnitzler, Paul .
PHYTOTHERAPY RESEARCH, 2010, 24 (05) :673-679
[5]   Genomic Predictions Using Low-Density SNP Markers, Pedigree and GWAS Information: A Case Study with the Non-Model Species Eucalyptus cladocalyx [J].
Ballesta, Paulina ;
Bush, David ;
Silva, Fabyano Fonseca ;
Mora, Freddy .
PLANTS-BASEL, 2020, 9 (01)
[6]   Genomic Prediction of Growth and Stem Quality Traits in Eucalyptus globulus Labill. at Its Southernmost Distribution Limit in Chile [J].
Ballesta, Paulina ;
Serra, Nicolle ;
Guerra, Fernando P. ;
Hasbun, Rodrigo ;
Mora, Freddy .
FORESTS, 2018, 9 (12)
[7]   Plant products as topical microbicide candidates: assessment of in vitro and in vivo activity against herpes simplex virus type 2 [J].
Bourne, KZ ;
Bourne, N ;
Reising, SF ;
Stanberry, LR .
ANTIVIRAL RESEARCH, 1999, 42 (03) :219-226
[8]   Effect of eucalyptus essential oil on respiratory bacteria and viruses [J].
Cermelli, Claudio ;
Fabio, Anna ;
Fabio, Giuliana ;
Quaglio, Paola .
CURRENT MICROBIOLOGY, 2008, 56 (01) :89-92
[9]  
Chalchat J. C., 1997, Journal of Essential Oil Research, V9, P159
[10]  
Chandorkar N., 2021, Phytomedicine, V1, DOI DOI 10.1016/J.PHYPLU.2021.100089